Showing results (91-100 of 499) with videos related to

Sort By:
Pageof 50
Current Topics in Medicinal Chemistry|September 2, 2015
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41Lu Lu, Fei Yu, Lifeng Cai, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 8, 2010
Fab crystallization and preliminary X-ray analysis of NC-1, an anti-HIV-1 antibody that recognizes the six-helix bundle core of gp41Lei Jin, Chungen Pan, Zhi Qi, et al.
Immunobiology|January 23, 2009
Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitorsJing Li, Xi Chen, Jinghe Huang, et al.
Microbes and Infection|February 5, 2020
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, ChinaFei Yu, Lanying Du, David M Ojcius, et al.
Immunobiology|December 6, 2005
Neutralization of HIV-1 primary isolate by ELDKWA-specific murine monoclonal antibodiesGeng Zhang, Hong Lu, Yun Lu, et al.
Biochemical and Biophysical Research Communications|May 26, 2009
High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmissionChungen Pan, Guiping Wang, Ming Liao, et al.
Journal of Medical Virology|September 13, 2022
Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseasesQiaoshuai Lan, Lijue Wang, Fanke Jiao, et al.
Journal of Virology|February 14, 2004
Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changesEve de Rosny, Russell Vassell, Shibo Jiang, et al.
The Journal of Biological Chemistry|January 11, 2005
Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120Shuwen Liu, Hong Lu, Jinkui Niu, et al.
Viruses|January 10, 2019
Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBDCong Wang, Chen Hua, Shuai Xia, et al.
Pageof 50